Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexandre C Pereira

Showing results (281-290 of 348) with videos related to

Pageof 35
Sort By:
Circulation. Genomic and Precision Medicine|August 26, 2020
Spatial and Functional Distribution of <i>MYBPC3</i> Pathogenic Variants and Clinical Outcomes in Patients With Hypertrophic CardiomyopathyAdam S Helms, Andrea D Thompson, Amelia A Glazier, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 21, 2012
Genetic and environmental risk factors in congenital heart disease functionally converge in protein networks driving heart developmentKasper Lage, Steven C Greenway, Jill A Rosenfeld, et al.
European Journal of Human Genetics : EJHG|January 26, 2017
Suggestive association between variants in IL1RAPL and asthma symptoms in Latin American childrenCintia Rodrigues Marques, Gustavo No Costa, Thiago Magalhães da Silva, et al.
JAMA Cardiology|October 21, 2020
Association of Damaging Variants in Genes With Increased Cancer Risk Among Patients With Congenital Heart DiseaseSarah U Morton, Akiko Shimamura, Peter E Newburger, et al.
Genome Medicine|January 31, 2019
Quantitative approaches to variant classification increase the yield and precision of genetic testing in Mendelian diseases: the case of hypertrophic cardiomyopathyRoddy Walsh, Francesco Mazzarotto, Nicola Whiffin, et al.
Circulation. Genomic and Precision Medicine|January 24, 2025
Sex-Specific Clinical and Genetic Factors Associated With Adverse Outcomes in Hypertrophic CardiomyopathyAlexandra Butters, Clare Arnott, Joanna Sweeting, et al.
Circulation|January 28, 2020
Myosin Sequestration Regulates Sarcomere Function, Cardiomyocyte Energetics, and Metabolism, Informing the Pathogenesis of Hypertrophic CardiomyopathyChristopher N Toepfer, Amanda C Garfinkel, Gabriela Venturini, et al.
Circulation. Genomic and Precision Medicine|May 11, 2023
Contribution of Previously Unrecognized RNA Splice-Altering Variants to Congenital Heart DiseaseMin Young Jang, Parth N Patel, Alexandre C Pereira, et al.
Elife|October 15, 2020
<i>GATA6</i> mutations in hiPSCs inform mechanisms for maldevelopment of the heart, pancreas, and diaphragmArun Sharma, Lauren K Wasson, Jon Al Willcox, et al.
JAMA Cardiology|March 5, 2025
Valsartan and Cardiac Remodeling in Early-Stage Hypertrophic Cardiomyopathy: The VANISH Randomized Clinical Trial Cardiac Magnetic Resonance SubstudyJohn W Ostrominski, Brian L Claggett, Michael Jerosch-Herold, et al.
Pageof 35

Showing results (281-290 of 348) with videos related to

Sort By:
Pageof 35
Circulation. Genomic and Precision Medicine|August 26, 2020
Spatial and Functional Distribution of <i>MYBPC3</i> Pathogenic Variants and Clinical Outcomes in Patients With Hypertrophic CardiomyopathyAdam S Helms, Andrea D Thompson, Amelia A Glazier, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 21, 2012
Genetic and environmental risk factors in congenital heart disease functionally converge in protein networks driving heart developmentKasper Lage, Steven C Greenway, Jill A Rosenfeld, et al.
European Journal of Human Genetics : EJHG|January 26, 2017
Suggestive association between variants in IL1RAPL and asthma symptoms in Latin American childrenCintia Rodrigues Marques, Gustavo No Costa, Thiago Magalhães da Silva, et al.
JAMA Cardiology|October 21, 2020
Association of Damaging Variants in Genes With Increased Cancer Risk Among Patients With Congenital Heart DiseaseSarah U Morton, Akiko Shimamura, Peter E Newburger, et al.
Genome Medicine|January 31, 2019
Quantitative approaches to variant classification increase the yield and precision of genetic testing in Mendelian diseases: the case of hypertrophic cardiomyopathyRoddy Walsh, Francesco Mazzarotto, Nicola Whiffin, et al.
Circulation. Genomic and Precision Medicine|January 24, 2025
Sex-Specific Clinical and Genetic Factors Associated With Adverse Outcomes in Hypertrophic CardiomyopathyAlexandra Butters, Clare Arnott, Joanna Sweeting, et al.
Circulation|January 28, 2020
Myosin Sequestration Regulates Sarcomere Function, Cardiomyocyte Energetics, and Metabolism, Informing the Pathogenesis of Hypertrophic CardiomyopathyChristopher N Toepfer, Amanda C Garfinkel, Gabriela Venturini, et al.
Circulation. Genomic and Precision Medicine|May 11, 2023
Contribution of Previously Unrecognized RNA Splice-Altering Variants to Congenital Heart DiseaseMin Young Jang, Parth N Patel, Alexandre C Pereira, et al.
Elife|October 15, 2020
<i>GATA6</i> mutations in hiPSCs inform mechanisms for maldevelopment of the heart, pancreas, and diaphragmArun Sharma, Lauren K Wasson, Jon Al Willcox, et al.
JAMA Cardiology|March 5, 2025
Valsartan and Cardiac Remodeling in Early-Stage Hypertrophic Cardiomyopathy: The VANISH Randomized Clinical Trial Cardiac Magnetic Resonance SubstudyJohn W Ostrominski, Brian L Claggett, Michael Jerosch-Herold, et al.
Pageof 35